TNF and Alzheimer disease: Tumor necrosis factor-alpha (TNFα) level was increased in the Ox-AD group compared to that in the control group, but there was no difference between the 11β-HSD1 inhibitor-treated Ox-AD group and the vehicle-treated Ox-AD group.